I. Introduction
Brachial plexus block is a reliable regional anaesthetic technique and a suitable alternative to general anaesthesia for upper limb surgery. The supraclavicular approach provides the most complete and reliable anaesthesia as it provides anaesthesia of the entire distal upper extremity in the most consistent, time efficient manner of the many brachial plexus technique. 1 The ability to administer this block with precision has become possible with the advent of ultrasound, peripheral nerve stimulator, echogenic needles, depth coded needles, non-stimulating and stimulating catheters. Local anaesthetics alone do not provide analgesia for more than 3-4 hours. Prolonging the duration of sensory and motor blockade of regional anaesthetic techniques is often desirable to provide intra operative anesthesia and analgesia in the post operative period without any systemic side effects. Several adjuncts have been studied to potentiate efficacy of brachial plexus block including opioids, midazolam, neostigmine, bicarbonate,hyaluronidase and α2 agonist. 2, 3 Dexamethasone, a derivative of synthetic glucocorticoid, is preferred because of its highly potent anti inflammatory and immunosuppressive effect. It causes skin vasoconstriction on topical application which decreases absorption of local anaesthetic agent and there by prolongs the duration of action. 4 The effect of dexamethasone is mediated by direct blockade of transmission in nociceptive C-fibres, reducing the release of inflammatory mediators andectopic neuronal discharge, and upregulation of potassium channels. 5 Perineural glucocorticoid is eventually absorbed and exerts systemic effects and intravenous steroids shown to improve postoperative pain and also decreases postoperative nausea and vomiting. 6 Ropivacaine, the S-enantiomer of S-1-propyl-2, 6 -pipecoloxylidide is an amino-amide local anesthetic with a chemical structure similar to that of bupivacaine. Numerous comparative studies between ropivacaine and bupivacaine suggested that ropivacaine produced less cardiac and central nervous system toxic effects, less motor block, and a similar duration of action of sensory analgesia. This favorable clinical profile prompted 
II. Materials and Methods
The study was conducted in a randomized double blind manner, in the department of anaesthesiology at Dr. D. Y. Patil Medical College and Hospital .Written informed consent was obtained from all patients willing to be part of the study. After the approval of the institutional ethics committee, the study was conducted on 60 healthy patients of both sex aged between 18-65 years. ASA grade I and II, undergoing upper extremity surgery and hemodynamically stable were included in the study. Patients with bleeding disorder or patients on anticoagulation therapy, uncooperative, underlying respiratory disease, history of drug allergy, abnormal psychological profile, convulsions and peripheral nerve diseases were excluded from the study. 60 patients were divided into two equal groups of 30 each. Group RD: Inj. 0.5% Ropivacaine 28ml with 2ml dexamethasone (8 mg) making total volume -30ml Group RS: Inj. 0.5% Ropivacaine 28ml with 2 ml Normal Saline making total volume -30ml.
Drug was prepared by an anesthesiologist who was not involved in the administration of anesthesia, patient care and data collection. The drug was given by a double blind method. Every patient was evaluated with a thorough pre-anesthetic checkup including routine preoperative investigations one day prior to surgery. Patients were asked to have 6 to 8 hours fasting before surgery. Pre-operative explanation of the procedure was done to gain confidence of the patient and written informed consent for surgery was taken.
In the operation theatre, intravenous (IV) line was secured with 20G intra cath and IV fluids were started. Routine monitors like pulse oxymetry (SPO 2 ), noninvasive blood pressure (NIBP), electrocardiogram (ECG) were attached before performing the procedure. Supraclavicular brachial plexus block was performed under all aseptic precautions in supine position with small bolster under the shoulder and head turned slightly to the opposite side. The arm to be anesthetized was adducted and the hand extended along the side towards the ipsilateral knee as far as possible. We used a nerve stimulator with a 22-G, 5-cm insulated needle for precise localization of the brachial plexus. A skin wheal was raised in the lateral border of middle scalene muscle 1.5-2 cms posterior to the midpoint of clavicle. The subclavian artery was usually be palpated at this site. Nerve locator was used, whose frequency was set at 2 Hz and intensity of the stimulating current was initially set to deliver 1 mA for 0.1ms. The insulated needle was inserted through the skin wheal in a posterior, caudal and medial direction until a distal motor response is elicited. As the nerve was approached, movement of the wrist or fingers elicited was identified and the current was gradually reduced to 0.4 mA. The end point taken was when hand twitches could be elicited at a current of 0.4 mA. Once this was achieved, the test drug in 0.5% Ropivacaine was given in 5 ml increments, aspirating before each bolus for blood and air, to avoid accidental intravascular injection. Patient was monitored closely after completing the local anaesthetic injection. The sensory level was assessed using a 24-gauge short beveled needle by bilateral loss of pin prick every 1 minute till the fixation of sensory level and attaining a maximum sensory level.
Assessment of sensory block: Onset of sensory block was evaluated by pin prick sensation. Dull sensation on pin prick, which was compared with the other arm, was taken as the time of onset of sensory blockade.
Onset of peak sensory blockade: it was taken from the time of administration of drug upto the time of complete loss of pinprick sensation at the forearm; and also no complaint of pain on manipulation of the fracture.
Assessment of motor block: The motor block was assessed with the help of modified bromage scale. Onset of motor blockade, was considered from the injection of drug upto the time when patient felt heaviness on abduction of arm, at shoulder or on achieving bromage scale 1 where 0-Able to raise the extended arm to 90 degree for a full 30 seconds; 1-Able to flex the elbow and move the fingers but unable to raise the extended arm. 2-Unable to flex the elbow but able to move the fingers. 3-Unable to move the arm, elbow or fingers.
Onset of peak motor blockade, was taken from the injection of drug upto the time of achieving bromage scale 2 or 3. Vital parameters were monitored every 5 mins for the first 15 mins and every 15 minutes till the end of the surgery. Patients were monitored for any adverse effects (cough, chest pain, hoarseness of voice). After surgery patient was shifted to post-operative recovery room and assessment of duration of analgesia was done upto 24 hours using VAS scale. Duration of analgesia was taken from the time of administration of drug to the time of giving first rescue analgesia. Statistical Analysis: All the Data were checked, filled up in the proforma and were analysed .The unpaired t-test and z-test were used for comparison between two groups. P < 0.05 value was considered significant.
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III. Results
The Demographic data of both the groups were comparable (Table 1 ) (p>0.05). Onset of Sensory block was earlier in group RD as compared with group R (p<0.05). There was no significant difference in the onset of motor block in the 2 groups (p>0.05). Onset of peak sensory block was earlier in RD than RS (p<0.05), however onset of peak motor was not significant enough. Total duration of sensory and motor blockade in group RD was longer than in group R (p<0.001). Longer postoperative analgesia was also seen in group RD. (P<0.001). There was no side effect in either of group and patients in both groups were haemodynamically stable. 
Table1: Demographic Data
IV. Discussion
Brachial plexus block is an easy and relatively safe procedure for upper limb surgeries. Ropivacaine provided better operating conditions, but the duration of analgesia is rarely maintained for more than 4-6 h. Addition of steroid to local anesthetics effectively and significantly prolongs the duration of analgesia as well as producing earlier onset of action. 7 Kumud et al in 2014 studied the efficacy of dexamethasone as an adjuvant to 0.5% ropivacaine for brachial plexus block and they observed faster onset time of sensory and motor block with dexamethasoneropivacaine combination as compared to ropivacaine with normal saline which is similar with our study. 8 The early onset of action might be due to synergistic action of dexamethasone with local anesthetics on blockage of nerve fibers. Ahmad et al in 2013 conducted same study and found that duration of effective sensory blockade was prolonged with 0.5% ropivacaine and dexamethasone combination. 4 In our study we also found, duration of effective sensory action with ropivacaine and dexamethasone lasted for 11.05 hours (p<0.5). The total duration of motor blockade lasted for 10.05 hours in group RD and 6.25 hours in group RS (p<0.05).
Similar results were observed in 2006 by Ali et al where the duration sensory blockade was significantly longer with 0.5% Ropivacaine and dexamethasone group (10.17 ± 1.13 hr) as compared to 0.5% Ropivacaine plain (6.5 ± 0.6 hr). 10 Similarly, in our study the duration of motor blockade was also longer in dexamethasone group (8.35 ± 0.81 hr) as compared to control group (7.42 ± 0.78 hrs). In present study, effective analgesia was significantly longer with addition of dexamethasone to0.5% ropivacaine and was 13.60 hours and 7.2 hours with plain 0.5% ropivacaine (P value was <0.05). In 2011 K.C. Cummings concluded that, dexamethasone prolongs analgesia from interescalene nerve blocks using ropivacaine or bupivacaine, with the effect being stronger with ropivacaine. 11 Shrestha and Maharjan in 2011 , showed that 8 mg of dexamethasone when added to a lignocaine and bupivacaine for supraclavicular brachial plexus block had a faster onset of action and longer duration of analgesia without any adverse effects. 12 In our study, rescue analgesia was given at VAS score ≥ 4. No significant difference was found in both groups in heart rate, systolic blood pressure, diastolic blood pressure at any time interval during monitoring. No significant intra-operative or post-operative complication like intra arterial or intra vascular placement of drugs, pneumothorax, neurotoxicity, cardiotoxicity, nausea and vomiting were found in either of the two groups. 
V. Conclusion
Dexamethasone (8mg) when added to 0.5% Ropivacaine fastens the onset of sensory and motor block. It provides longer duration of effective sensory and motor block and prolongs the duration of effective post operative analgesia in patients undergoing surgeries under suprclavicular brachial plexus block.
